February 27, 2018, Updated April 21, 2020
Prof. Moussa Youdim with the drug he developed.
Prof. Moussa Youdim with the drug he developed. Photo by Nati Shohat

• Technion Prof. Moussa Youdim publishes a paper claiming the compound Rasagiline can fight Parkinson’s disease. Three years later, Israeli drug company Teva Pharmaceuticals develops Azilect and begins marketing it in Europe (2005) and the United States (2006).

• Jerusalem celebrates its 3,000th anniversary of King David establishing it as his capital city.

Fighting for Israel's truth

We cover what makes life in Israel so special — it's people. A non-profit organization, ISRAEL21c's team of journalists are committed to telling stories that humanize Israelis and show their positive impact on our world. You can bring these stories to life by making a donation of $6/month. 

Donate Now